Cold War tensions and the polio vaccine Sabin vaccine from the Soviet side. However other Soviet virologists argued that the Salk vaccine could be considered safe, since the Americans tested it on their own people. They considered that the Sabin vaccine must be potentially dangerous because the Americans did not wish to test it on their own society. The documented achievement of the Sabin-Chumakov collaboration eventually trumped the ideological differences of the Cold War. Their oral live-virus vaccine became federally licensed in 1962, and used for over three decades to help eliminate polio globally, replacing the Salk vaccine. Using these vaccines, the threat of polio remains only
Sabin Vaccine Institute Development, the Global Network for Neglected Tropical Diseases, and Vaccine Advocacy and Education. Through its Product Development Partnership (PDP), Sabin has worked with organizations such as King Saud University, Texas Children's Hospital Center, International Vaccine Institute, and George Washington University School of Medicine & Health Sciences toward its goals, with funding and support from the Bill & Melinda Gates Foundation, the National Institute of Allergy and Infectious Diseases, the Dutch Ministry of Foreign Affairs, the Brazilian Ministry of Health and other benefactors. In 2012, Sabin partnered with International Vaccine Institute to combine their research, development, and promotion efforts in Asia,